These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 31794815)

  • 1. A Preliminary Study on the Impact of Detrusor Overactivity on the Efficacy of Selective Bladder Denervation for the Treatment of Female Refractory Overactive Bladder.
    Brière R; Versi E; Richard PO; Gratton M; Tu LM
    Urology; 2020 Feb; 136():88-94. PubMed ID: 31794815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Six-Month Results of Selective Bladder Denervation in Women with Refractory Overactive Bladder.
    De Wachter S; Benson KD; Dmochowski RR; Rovner ES; Versi E; Miller LE; Tu LM
    J Urol; 2019 Mar; 201(3):573-580. PubMed ID: 30240691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. One-year results with selective bladder denervation in women with refractory overactive bladder.
    Rovner ES; Versi E; Le Mai T; Dmochowski RR; De Wachter S
    Neurourol Urodyn; 2019 Nov; 38(8):2178-2184. PubMed ID: 31359508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superiority of fesoterodine 8 mg vs 4 mg in reducing urgency urinary incontinence episodes in patients with overactive bladder: results of the randomised, double-blind, placebo-controlled EIGHT trial.
    Chapple C; Schneider T; Haab F; Sun F; Whelan L; Scholfield D; Dragon E; Mangan E
    BJU Int; 2014 Sep; 114(3):418-26. PubMed ID: 24552358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial clinical experience with selective bladder denervation for refractory overactive bladder.
    Tu LM; De Wachter S; Robert M; Dmochowski RR; Miller LE; Everaert K
    Neurourol Urodyn; 2019 Feb; 38(2):644-652. PubMed ID: 30499155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to fesoterodine in patients with an overactive bladder and urgency urinary incontinence is independent of the urodynamic finding of detrusor overactivity.
    Nitti VW; Rovner ES; Bavendam T
    BJU Int; 2010 May; 105(9):1268-75. PubMed ID: 19889062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does urinary urgency drive urinary frequency in overactive bladder?
    Versi E; Rovner ES; Dmochowski RR; Tu LM; De Wachter S
    Low Urin Tract Symptoms; 2022 Jul; 14(4):242-247. PubMed ID: 35233968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder.
    Ginsberg D; Schneider T; Kelleher C; Van Kerrebroeck P; Swift S; Creanga D; Martire DL
    BJU Int; 2013 Aug; 112(3):373-85. PubMed ID: 23826844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of tension-free vaginal tape on overactive bladder symptoms in women with stress urinary incontinence: significance of detrusor overactivity.
    Choe JH; Choo MS; Lee KS
    J Urol; 2008 Jan; 179(1):214-9. PubMed ID: 18001792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle.
    Dokmeci F; Cetinkaya SE; Seval MM; Dai O
    Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urgency severity scale could predict urodynamic detrusor overactivity in patients with overactive bladder syndrome.
    Chung SD; Liao CH; Chen YC; Kuo HC
    Neurourol Urodyn; 2011 Sep; 30(7):1300-4. PubMed ID: 21560153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urodynamic findings in women with refractory overactive bladder symptoms.
    Al-Zahrani AA; Gajewski J
    Int J Urol; 2016 Jan; 23(1):75-9. PubMed ID: 26417863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-operative opening detrusor pressure is predictive of detrusor overactivity following TVT in patients with pre-operative mixed urinary incontinence.
    Panayi DC; Duckett J; Digesu GA; Camarata M; Basu M; Khullar V
    Neurourol Urodyn; 2009; 28(1):82-5. PubMed ID: 19089898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective and subjective improvement in children with idiopathic detrusor overactivity after intravesical botulinum toxin injection: A preliminary report.
    Al Edwan GM; Mansi HH; Atta ONM; Shaath MM; Al Adwan R; Mahafza W; Afram KM; Ababneh O; Al Adwan D; Muheilan MM
    J Pediatr Surg; 2019 Mar; 54(3):595-599. PubMed ID: 29887168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective bladder denervation for overactive bladder (OAB) syndrome: From concept to healing outcomes using the ovine model.
    Fugett J; Phillips L; Tobin E; Whitbrook E; Bennett H; Shrout J; Coad JE
    Neurourol Urodyn; 2018 Sep; 37(7):2097-2105. PubMed ID: 29603776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does urodynamic verification of overactive bladder determine treatment success? Results from a randomized placebo-controlled study.
    Malone-Lee JG; Al-Buheissi S
    BJU Int; 2009 Apr; 103(7):931-7. PubMed ID: 19281469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of coexistent overactive bladder symptoms in women with urodynamic urinary incontinence following anti-incontinence surgery.
    Liang CC; Hsieh WC; Huang L
    Int Urogynecol J; 2017 Apr; 28(4):605-611. PubMed ID: 27678141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.
    Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T
    Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of fesoterodine and tolterodine extended release for the treatment of overactive bladder: a head-to-head placebo-controlled trial.
    Herschorn S; Swift S; Guan Z; Carlsson M; Morrow JD; Brodsky M; Gong J
    BJU Int; 2010 Jan; 105(1):58-66. PubMed ID: 20132103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treat or Wait? Natural Perioperative Course of Overactive Bladder Symptoms at the Time of Midurethral Sling Placement.
    Heliker BD; Kenton K; Komar A; Mueller MG; Lewicky-Gaupp C; Abernethy M
    Female Pelvic Med Reconstr Surg; 2021 Feb; 27(2):e348-e351. PubMed ID: 32947550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.